Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
143.3 EUR | -0.50% |
|
+0.81% | +17.36% |
Jul. 15 | Global markets live: Airbus, Burberry, AT&T, Boeing, Vinfast... | ![]() |
Jul. 15 | AstraZeneca: acquisition of Amolyt Pharma finalized | CF |
Sales 2024 * | 51.62B 47.35B | Sales 2025 * | 55.49B 50.9B | Capitalization | 244B 224B |
---|---|---|---|---|---|
Net income 2024 * | 8.73B 8.01B | Net income 2025 * | 10.46B 9.6B | EV / Sales 2024 * | 5.13 x |
Net Debt 2024 * | 20.99B 19.26B | Net Debt 2025 * | 14.52B 13.32B | EV / Sales 2025 * | 4.65 x |
P/E ratio 2024 * |
27.9
x | P/E ratio 2025 * |
23.2
x | Employees | 89,900 |
Yield 2024 * |
1.96% | Yield 2025 * |
2.07% | Free-Float | 96.64% |
Latest transcript on AstraZeneca PLC
1 day | -0.42% | ||
1 week | +0.81% | ||
Current month | -2.49% | ||
1 month | -3.38% | ||
3 months | +11.81% | ||
6 months | +16.31% | ||
Current year | +17.36% |
![Extreme 141.6](/images/extremecours_fleche.png)
![Extreme 141.45](/images/extremecours_fleche.png)
![Extreme 112.45](/images/extremecours_fleche.png)
![Extreme 112.45](/images/extremecours_fleche.png)
![Extreme 94](/images/extremecours_fleche.png)
![Extreme 64.57](/images/extremecours_fleche.png)
![Extreme 47.738](/images/extremecours_fleche.png)
Managers | Title | Age | Since |
---|---|---|---|
Pascal Soriot
CEO | Chief Executive Officer | 64 | 12-09-30 |
Aradhana Sarin
DFI | Director of Finance/CFO | 50 | 21-07-31 |
Sharon Barr
CTO | Chief Tech/Sci/R&D Officer | - | 23-07-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Sherilyn McCoy
BRD | Director/Board Member | 66 | 17-09-30 |
Philip Broadley
BRD | Director/Board Member | 63 | 17-04-26 |
Director/Board Member | 68 | 99-03-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-07-16 | 143 | -0.73% | 20 |
24-07-15 | 144 | -1.64% | 586 |
24-07-12 | 146.4 | +0.45% | 450 |
24-07-11 | 145.8 | +1.82% | 90 |
24-07-10 | 143.2 | +0.95% | 2,085 |
Delayed Quote Deutsche Boerse AG, July 16, 2024 at 03:12 am EDT
More quotes![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+63.05% | 856B | |
+39.44% | 631B | |
-4.78% | 359B | |
+17.52% | 325B | |
+8.43% | 297B | |
+5.19% | 234B | |
+16.26% | 226B | |
+14.63% | 177B | |
+1.08% | 165B |
- Stock Market
- Equities
- AZN Stock
- ZEG Stock